Analyst Activity – Shore Capital Reiterates Buy on Exova Group Plc (LON:EXO)

Analyst Ratings For Exova Group Plc (LON:EXO)

Story continues below

Today, Shore Capital reiterated its Buy rating on Exova Group Plc (LON:EXO).

There are 6 buy ratings on the stock.

The current consensus rating on Exova Group Plc (LON:EXO) is Buy (Score: 3.00) with a consensus target price of GBX 225 per share, a potential .

Some recent analyst ratings include

  • 2/28/2017-Shore Capital Reiterated Rating of Buy.
  • 1/24/2017-Peel Hunt Reiterated Rating of Buy.
  • 11/24/2016-Credit Suisse Group Reiterated Rating of Outperform.


    About Exova Group Plc (LON:EXO)
    Exova Group plc is a United Kingdom-based provider of testing and advisory services. The Company is a laboratory-based testing company operating approximately 140 laboratories and offices in over 30 countries throughout Europe, the Americas, the Middle East and Asia/Asia Pacific. The Company’s segments include Europe, Americas and Rest of World. The Company serves a range of markets, including Aerospace; Oil and Gas, and Industrials; Product and Certification, and Health Sciences. It operates primarily in the Testing segment of the Testing, Inspection and Certification (TIC) sector. The Company also has a Certification business and is engaged in providing Inspection services in a number of markets and geographies.

    Recent Trading Activity for Exova Group Plc (LON:EXO)
    Shares of Exova Group Plc closed the previous trading session at 210.00 0.00 0.00% with 4,466 shares trading hands.

    An ad to help with our costs